| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.0105-2896.2005.00250.X |
| P698 | PubMed publication ID | 15790359 |
| P50 | author | Fiona Powrie | Q5451098 |
| Janine Coombes | Q42657390 | ||
| P2093 | author name string | Kevin J Maloy | |
| Holm H Uhlig | |||
| Nicholas J Robinson | |||
| P2860 | cites work | CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells | Q36361889 |
| T cell regulation as a side effect of homeostasis and competition | Q36370619 | ||
| CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 | ||
| Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 | ||
| Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 | ||
| Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 | ||
| Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis | Q36376571 | ||
| Peripheral selection of T cell repertoires: the role of continuous thymus output | Q36380653 | ||
| T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells | Q36400646 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| THE DEVELOPMENT OF THE BACTERIAL FLORA IN THE GASTROINTESTINAL TRACT OF MICE. | Q42830078 | ||
| Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. | Q44021327 | ||
| TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice | Q44714971 | ||
| Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants | Q47644499 | ||
| Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. | Q47777664 | ||
| Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 | ||
| CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. | Q52833960 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms | Q24673863 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells | Q24678065 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. | Q30870101 | ||
| Animal models of mucosal inflammation and their relation to human inflammatory bowel disease | Q33814949 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. | Q33977505 | ||
| Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation | Q34008033 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 | ||
| The immunological and genetic basis of inflammatory bowel disease | Q34216426 | ||
| Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells | Q34299001 | ||
| T cell homeostasis and systemic autoimmunity | Q34328737 | ||
| Regulatory T cells in the control of immune pathology. | Q34348983 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Transforming growth factor-beta in T-cell biology | Q34572232 | ||
| In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro | Q35171080 | ||
| Transcription factors in autoimmunity | Q35589862 | ||
| INDIGENOUS, NORMAL, AND AUTOCHTHONOUS FLORA OF THE GASTROINTESTINAL TRACT | Q36267558 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 184-194 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Regulatory T cells and intestinal homeostasis | |
| P478 | volume | 204 |
| Q42930045 | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Impairs Stable Establishment of Oral Tolerance in Mice |
| Q33489543 | A decreased frequency of regulatory T cells in patients with common variable immunodeficiency |
| Q29614266 | A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism |
| Q40808062 | A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes |
| Q34696683 | A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells |
| Q28476563 | Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis |
| Q41762576 | Adaptive human regulatory T cells: myth or reality? |
| Q36593575 | Agonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire |
| Q36166154 | An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes |
| Q88407288 | An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis |
| Q37337702 | An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice |
| Q26777430 | Animal models to study acute and chronic intestinal inflammation in mammals |
| Q34580564 | Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients |
| Q34598995 | Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. |
| Q36327362 | Antigen-specific induction of regulatory T cells for type 1 diabetes therapy |
| Q37073835 | Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer |
| Q42523517 | Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action |
| Q56901901 | Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo |
| Q46135706 | Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion |
| Q52889308 | CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis. |
| Q37366174 | CD25+ T cells induce Helicobacter pylori-specific CD25- T-cell anergy but are not required to maintain persistent hyporesponsiveness |
| Q51029379 | CD4+ CD25+ Treg regulate the contribution of CD8+ T-cell subsets in repopulation of the lymphopenic environment. |
| Q36403998 | CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function |
| Q34718815 | CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. |
| Q37017450 | CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells |
| Q35944770 | CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice |
| Q61779891 | Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis |
| Q36371687 | Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms |
| Q64092922 | Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3 Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis |
| Q39398744 | Comparison of clinical features, treatment, and outcomes of collagenous sprue, celiac disease, and collagenous colitis |
| Q89448413 | Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses |
| Q34360325 | Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation |
| Q36563563 | Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. |
| Q85052737 | Dendritic cells in tolerance induction for the treatment of autoimmune diseases |
| Q34077486 | Development of thymically derived natural regulatory T cells |
| Q36494866 | Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA. |
| Q50949144 | Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice. |
| Q37868128 | Effect of biologic agents on regulatory T cells. |
| Q54561722 | Effects of different immunosuppressive regimens on regulatory T-cells in noninflamed colon of liver transplant recipients. |
| Q36176048 | Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice |
| Q34728538 | Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice |
| Q35150799 | Enhanced inflammatory potential of CD4+ T-cells that lack proteasome immunosubunit expression, in a T-cell transfer-based colitis model |
| Q37049828 | Enlarged colitogenic T cell population paradoxically supports colitis prevention through the B-lymphocyte-dependent peripheral generation of CD4(+)Foxp3(+) Treg cells |
| Q36429822 | Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. |
| Q56891093 | Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9 |
| Q38709455 | Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial. |
| Q37288012 | Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria |
| Q43429839 | Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease |
| Q42279415 | Functional heterogeneity of gut-resident regulatory T cells |
| Q50517775 | Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid. |
| Q40165972 | Genome-wide expression profiling during protection from colitis by regulatory T cells |
| Q38960902 | Gut memories do not fade: epigenetic regulation of lasting gut homing receptor expression in CD4+ memory T cells |
| Q35737946 | HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responses |
| Q37723134 | Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice |
| Q39879767 | Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission |
| Q34164041 | Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts |
| Q29614262 | How regulatory T cells work |
| Q41867495 | Hsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways |
| Q35009480 | Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo |
| Q47145934 | IL-35 may maintain homeostasis of the immune microenvironment in periodontitis |
| Q46080853 | Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis |
| Q99403342 | Immune and microRNA responses to Helicobacter muridarum infection and indole-3-carbinol during colitis |
| Q36593757 | Immune privilege in sites of chronic infection: Leishmania and regulatory T cells |
| Q59098464 | Immunology: Soothing intestinal sugars |
| Q29614272 | Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota |
| Q41855521 | Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid |
| Q36563558 | Infectious tolerance and the long-term acceptance of transplanted tissue |
| Q37982378 | Inflammation and adaptive immunity in Parkinson's disease |
| Q42726346 | Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells |
| Q37401280 | Innate and adaptive immunity for the pathobiology of Parkinson's disease |
| Q42083897 | Interleukin-23 drives intestinal inflammation through direct activity on T cells |
| Q36853829 | Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles |
| Q36209709 | Intestinal macrophages: unique effector cells of the innate immune system |
| Q35132967 | Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis |
| Q37185263 | Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice |
| Q35400138 | Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice |
| Q35992006 | Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency |
| Q90317935 | Microanatomical dissection of human intestinal T-cell immunity reveals site-specific changes in gut-associated lymphoid tissues over life |
| Q39924114 | Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus. |
| Q37123770 | Microbial host interactions in IBD: implications for pathogenesis and therapy |
| Q37399077 | Morbus Crohn--a disease of failing macroautophagy in the immune system? |
| Q51765584 | Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. |
| Q42114183 | Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells |
| Q40066564 | OX40 is required for regulatory T cell-mediated control of colitis |
| Q36755475 | Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease |
| Q47171646 | Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype. |
| Q37957125 | Pathways towards an effective immunotherapy for Parkinson's disease |
| Q57794439 | Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development |
| Q35741869 | Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? |
| Q35895310 | Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease |
| Q28273923 | Protective and pro-inflammatory roles of intestinal bacteria |
| Q36412789 | RANKL-RANK interaction in immune regulatory systems |
| Q35859478 | Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia. |
| Q34475294 | Regulatory T cell kinetics in the peripheral blood of patients with Crohn's disease |
| Q46226178 | Regulatory T cells control VEGF-dependent skin inflammation |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q36549731 | Regulatory T cells in microbial infection |
| Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
| Q36457546 | Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD. |
| Q36978927 | Role of T cells and dendritic cells in glomerular immunopathology. |
| Q30438775 | Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies? |
| Q35052712 | Role of the enteric microbiota in intestinal homeostasis and inflammation |
| Q79197074 | Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis |
| Q36395001 | STAT3 in immune responses and inflammatory bowel diseases |
| Q85244059 | Salmon cartilage proteoglycan suppresses mouse experimental colitis through induction of Foxp3+ regulatory T cells |
| Q81248942 | Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity |
| Q38164258 | Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases |
| Q38306073 | Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease |
| Q37201964 | Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures |
| Q28269450 | Severe spruelike enteropathy associated with olmesartan |
| Q33913016 | Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32). |
| Q44400760 | Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease |
| Q24648636 | Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine |
| Q33506614 | Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking |
| Q47810553 | Subclinical intestinal inflammation in patients with Crohn's disease following bowel resection: a smoldering fire |
| Q35237468 | Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance |
| Q33772861 | Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells |
| Q37100252 | T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade |
| Q83171266 | T cells join the Blimp-1 brigade |
| Q37576748 | T-bet-/- RAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships |
| Q37677358 | Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites |
| Q59806975 | The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections |
| Q36229690 | The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells |
| Q38008353 | The ambiguity in immunology |
| Q34157927 | The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease |
| Q37771861 | The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models |
| Q28258462 | The inhibitory cytokine IL-35 contributes to regulatory T-cell function |
| Q42112037 | The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo |
| Q39285665 | The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. |
| Q36164906 | The role of mucosal T lymphocytes in regulating intestinal inflammation |
| Q36563513 | The roles for cytokines in the generation and maintenance of regulatory T cells |
| Q24314985 | The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells |
| Q41926798 | The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals |
| Q36987442 | Therapeutic leukocytapheresis for inflammatory bowel disease |
| Q24320083 | Tracking antigen-specific T-cells during clinical tolerance induction in humans |
| Q36711547 | Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease |
| Q41958444 | Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation |
| Q37279157 | Why study animal models of IBD? |
Search more.